The global market for Solid Phase Carrier Resin for Peptide Drug Synthesis was valued at US$ 132 million in the year 2024 and is projected to reach a revised size of US$ 269 million by 2031, growing at a CAGR of 10.6% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Solid Phase Carrier Resin for Peptide Drug Synthesis competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Solid phase carrier resin is a crucial material in peptide drug synthesis, enabling efficient peptide preparation through Solid Phase Peptide Synthesis (SPPS). Compared to traditional liquid-phase synthesis, SPPS offers greater ease of operation and facilitates automation and high-throughput production. By using solid phase carrier resin as the reaction medium, repetitive coupling and deprotection steps can be executed more efficiently, significantly improving peptide yield and purity. As SPPS can rapidly respond to the growing market demand for peptide drugs, it has become the mainstream technology in modern peptide drug research and manufacturing, widely applied in pharmaceuticals, biotechnology, and medical research.
North American market for Solid Phase Carrier Resin for Peptide Drug Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Solid Phase Carrier Resin for Peptide Drug Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Solid Phase Carrier Resin for Peptide Drug Synthesis include Sunresin, Shandong Lukang, Tianjin Nankai Hecheng Science & Technology, Zhejiang Zhengguang, Jiangsu Haipu Functional Materials, RawPEG, Merck, CEM Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Solid Phase Carrier Resin for Peptide Drug Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Phase Carrier Resin for Peptide Drug Synthesis.
The Solid Phase Carrier Resin for Peptide Drug Synthesis market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid Phase Carrier Resin for Peptide Drug Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Phase Carrier Resin for Peptide Drug Synthesis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sunresin
Shandong Lukang
Tianjin Nankai Hecheng Science & Technology
Zhejiang Zhengguang
Jiangsu Haipu Functional Materials
RawPEG
Merck
CEM Corporation
Segment by Type
Hydroxyl Resins
Chloromethyl Resins
Amino Resins
Others
Segment by Application
Orthopedics
Cardiovascular
Metabolic Diseases
Tumors
Others
Production by Region
North America
Europe
China
Japan
India
Southeast Asia
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Solid Phase Carrier Resin for Peptide Drug Synthesis manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Solid Phase Carrier Resin for Peptide Drug Synthesis by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Solid Phase Carrier Resin for Peptide Drug Synthesis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Solid Phase Carrier Resin for Peptide Drug Synthesis Market Overview
1.1 Product Definition
1.2 Solid Phase Carrier Resin for Peptide Drug Synthesis by Type
1.2.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Hydroxyl Resins
1.2.3 Chloromethyl Resins
1.2.4 Amino Resins
1.2.5 Others
1.3 Solid Phase Carrier Resin for Peptide Drug Synthesis by Application
1.3.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Orthopedics
1.3.3 Cardiovascular
1.3.4 Metabolic Diseases
1.3.5 Tumors
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Estimates and Forecasts (2020-2031)
1.4.4 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Market Share by Manufacturers (2020-2025)
2.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Solid Phase Carrier Resin for Peptide Drug Synthesis, Industry Ranking, 2023 VS 2024
2.4 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Solid Phase Carrier Resin for Peptide Drug Synthesis, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Solid Phase Carrier Resin for Peptide Drug Synthesis, Product Offered and Application
2.8 Global Key Manufacturers of Solid Phase Carrier Resin for Peptide Drug Synthesis, Date of Enter into This Industry
2.9 Solid Phase Carrier Resin for Peptide Drug Synthesis Market Competitive Situation and Trends
2.9.1 Solid Phase Carrier Resin for Peptide Drug Synthesis Market Concentration Rate
2.9.2 Global 5 and 10 Largest Solid Phase Carrier Resin for Peptide Drug Synthesis Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Solid Phase Carrier Resin for Peptide Drug Synthesis Production by Region
3.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value by Region (2020-2031)
3.2.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Solid Phase Carrier Resin for Peptide Drug Synthesis by Region (2026-2031)
3.3 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Volume by Region (2020-2031)
3.4.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Solid Phase Carrier Resin for Peptide Drug Synthesis by Region (2026-2031)
3.5 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Market Price Analysis by Region (2020-2025)
3.6 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production and Value, Year-over-Year Growth
3.6.1 North America Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Estimates and Forecasts (2020-2031)
3.6.5 India Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Estimates and Forecasts (2020-2031)
3.6.6 Southeast Asia Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Estimates and Forecasts (2020-2031)
4 Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption by Region
4.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption by Region (2020-2031)
4.2.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption by Region (2020-2025)
4.2.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Solid Phase Carrier Resin for Peptide Drug Synthesis Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production by Type (2020-2031)
5.1.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production by Type (2020-2025)
5.1.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production by Type (2026-2031)
5.1.3 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Market Share by Type (2020-2031)
5.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value by Type (2020-2031)
5.2.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value by Type (2020-2025)
5.2.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value by Type (2026-2031)
5.2.3 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Market Share by Type (2020-2031)
5.3 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Price by Type (2020-2031)
6 Segment by Application
6.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production by Application (2020-2031)
6.1.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production by Application (2020-2025)
6.1.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production by Application (2026-2031)
6.1.3 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Market Share by Application (2020-2031)
6.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value by Application (2020-2031)
6.2.1 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value by Application (2020-2025)
6.2.2 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value by Application (2026-2031)
6.2.3 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Production Value Market Share by Application (2020-2031)
6.3 Global Solid Phase Carrier Resin for Peptide Drug Synthesis Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Sunresin
7.1.1 Sunresin Solid Phase Carrier Resin for Peptide Drug Synthesis Company Information
7.1.2 Sunresin Solid Phase Carrier Resin for Peptide Drug Synthesis Product Portfolio
7.1.3 Sunresin Solid Phase Carrier Resin for Peptide Drug Synthesis Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Sunresin Main Business and Markets Served
7.1.5 Sunresin Recent Developments/Updates
7.2 Shandong Lukang
7.2.1 Shandong Lukang Solid Phase Carrier Resin for Peptide Drug Synthesis Company Information
7.2.2 Shandong Lukang Solid Phase Carrier Resin for Peptide Drug Synthesis Product Portfolio
7.2.3 Shandong Lukang Solid Phase Carrier Resin for Peptide Drug Synthesis Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Shandong Lukang Main Business and Markets Served
7.2.5 Shandong Lukang Recent Developments/Updates
7.3 Tianjin Nankai Hecheng Science & Technology
7.3.1 Tianjin Nankai Hecheng Science & Technology Solid Phase Carrier Resin for Peptide Drug Synthesis Company Information
7.3.2 Tianjin Nankai Hecheng Science & Technology Solid Phase Carrier Resin for Peptide Drug Synthesis Product Portfolio
7.3.3 Tianjin Nankai Hecheng Science & Technology Solid Phase Carrier Resin for Peptide Drug Synthesis Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Tianjin Nankai Hecheng Science & Technology Main Business and Markets Served
7.3.5 Tianjin Nankai Hecheng Science & Technology Recent Developments/Updates
7.4 Zhejiang Zhengguang
7.4.1 Zhejiang Zhengguang Solid Phase Carrier Resin for Peptide Drug Synthesis Company Information
7.4.2 Zhejiang Zhengguang Solid Phase Carrier Resin for Peptide Drug Synthesis Product Portfolio
7.4.3 Zhejiang Zhengguang Solid Phase Carrier Resin for Peptide Drug Synthesis Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Zhejiang Zhengguang Main Business and Markets Served
7.4.5 Zhejiang Zhengguang Recent Developments/Updates
7.5 Jiangsu Haipu Functional Materials
7.5.1 Jiangsu Haipu Functional Materials Solid Phase Carrier Resin for Peptide Drug Synthesis Company Information
7.5.2 Jiangsu Haipu Functional Materials Solid Phase Carrier Resin for Peptide Drug Synthesis Product Portfolio
7.5.3 Jiangsu Haipu Functional Materials Solid Phase Carrier Resin for Peptide Drug Synthesis Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Jiangsu Haipu Functional Materials Main Business and Markets Served
7.5.5 Jiangsu Haipu Functional Materials Recent Developments/Updates
7.6 RawPEG
7.6.1 RawPEG Solid Phase Carrier Resin for Peptide Drug Synthesis Company Information
7.6.2 RawPEG Solid Phase Carrier Resin for Peptide Drug Synthesis Product Portfolio
7.6.3 RawPEG Solid Phase Carrier Resin for Peptide Drug Synthesis Production, Value, Price and Gross Margin (2020-2025)
7.6.4 RawPEG Main Business and Markets Served
7.6.5 RawPEG Recent Developments/Updates
7.7 Merck
7.7.1 Merck Solid Phase Carrier Resin for Peptide Drug Synthesis Company Information
7.7.2 Merck Solid Phase Carrier Resin for Peptide Drug Synthesis Product Portfolio
7.7.3 Merck Solid Phase Carrier Resin for Peptide Drug Synthesis Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Merck Main Business and Markets Served
7.7.5 Merck Recent Developments/Updates
7.8 CEM Corporation
7.8.1 CEM Corporation Solid Phase Carrier Resin for Peptide Drug Synthesis Company Information
7.8.2 CEM Corporation Solid Phase Carrier Resin for Peptide Drug Synthesis Product Portfolio
7.8.3 CEM Corporation Solid Phase Carrier Resin for Peptide Drug Synthesis Production, Value, Price and Gross Margin (2020-2025)
7.8.4 CEM Corporation Main Business and Markets Served
7.8.5 CEM Corporation Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Solid Phase Carrier Resin for Peptide Drug Synthesis Industry Chain Analysis
8.2 Solid Phase Carrier Resin for Peptide Drug Synthesis Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Solid Phase Carrier Resin for Peptide Drug Synthesis Production Mode & Process Analysis
8.4 Solid Phase Carrier Resin for Peptide Drug Synthesis Sales and Marketing
8.4.1 Solid Phase Carrier Resin for Peptide Drug Synthesis Sales Channels
8.4.2 Solid Phase Carrier Resin for Peptide Drug Synthesis Distributors
8.5 Solid Phase Carrier Resin for Peptide Drug Synthesis Customer Analysis
9 Solid Phase Carrier Resin for Peptide Drug Synthesis Market Dynamics
9.1 Solid Phase Carrier Resin for Peptide Drug Synthesis Industry Trends
9.2 Solid Phase Carrier Resin for Peptide Drug Synthesis Market Drivers
9.3 Solid Phase Carrier Resin for Peptide Drug Synthesis Market Challenges
9.4 Solid Phase Carrier Resin for Peptide Drug Synthesis Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Sunresin
Shandong Lukang
Tianjin Nankai Hecheng Science & Technology
Zhejiang Zhengguang
Jiangsu Haipu Functional Materials
RawPEG
Merck
CEM Corporation
听
听
*If Applicable.
